Paclitaxel (Taxol) treatment for refractory ovarian cancer: Phase II clinical trial
- 1 June 1994
- journal article
- clinical trial
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 170 (6) , 1666-1671
- https://doi.org/10.1016/s0002-9378(94)70338-8
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- The challenge of ovarian cancerCA: A Cancer Journal for Clinicians, 1992
- Phase I study of taxol and granulocyte colony-stimulating factor in patients with refractory ovarian cancer.Journal of Clinical Oncology, 1992
- Taxol: A new agent active in melanoma and ovarian cancerPublished by Springer Nature ,1992
- Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial NeoplasmsAnnals of Internal Medicine, 1989
- Toxicity and response criteria of the Eastern Cooperative Oncology GroupAmerican Journal of Clinical Oncology, 1982
- Promotion of microtubule assembly in vitro by taxolNature, 1979